Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Frontiers in Oncology|August 29, 2022
Cyclin-dependent kinase inhibitors in malignant hematopoiesisAlessia Schirripa, Veronika Sexl, Karoline KollmannInternational Journal of Cancer|May 15, 2020
The role of CDK6 in cancerSofie Nebenfuehr, Karoline Kollmann, Veronika SexlOncotarget|July 27, 2011
c-JUN prevents methylation of p16(INK4a) (and Cdk6): the villain turned bodyguardKaroline Kollmann, Gerwin Heller, Veronika SexlPharmaceuticals (Basel, Switzerland)|December 1, 2020
CDK4/6 and MAPK-Crosstalk as Opportunity for Cancer TreatmentLisa Scheiblecker, Karoline Kollmann, Veronika SexlInternational Journal of Molecular Sciences|April 9, 2020
CDK6 Inhibition: A Novel Approach in AML ManagementIris Z Uras, Veronika Sexl, Karoline KollmannOncotarget|March 13, 2019
The interplay of CDK4 and CDK6 in melanomaKaroline Kollmann, Coralie Briand, Florian Bellutti, et al.Iscience|November 18, 2020
The Effect of CDK6 Expression on DNA Methylation and DNMT3B RegulationGerwin Heller, Sofie Nebenfuehr, Florian Bellutti, et al.Biochimie|June 13, 2012
Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphomaMelanie R Hassler, Aleksandra Klisaroska, Karoline Kollmann, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphomaJudith Lind, Roland Hellinger, Petra Kudweis, et al.Oncotarget|December 22, 2011
Putting the brakes on mammary tumorigenesis: loss of STAT1 predisposes to intraepithelial neoplasiasChristine Schneckenleithner, Zsuzsanna Bago-Horvath, Helmut Dolznig, et al.Pageof 4